Alaunos Therapeutics (TCRT) Prepaid Assets (2009 - 2026)
Alaunos Therapeutics (TCRT) reported Prepaid Assets of $616000.0 for Q1 2026, down 17.43% on a YoY basis from $746000.0 in Q1 2025, and up 2.67% quarter-over-quarter from $600000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Prepaid Assets (2009 - 2026) Analysis & Trends
Alaunos Therapeutics has reported Prepaid Assets for 18 years, with the latest figure at $616000.0 in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets fell 17.43% year-over-year to $616000.0; the trailing twelve-month figure through Mar 2026 stood at $616000.0 (down 17.43% YoY), and the FY2025 full-year result was $600000.0, down 63.83% from the prior year.
- Prepaid Assets for Q1 2026 stood at $616000.0, up from $600000.0 in the prior quarter.
- The five-year high for Prepaid Assets was $2.2 million in Q2 2024, with the low at $457000.0 in Q2 2023.
- Historically, Prepaid Assets has averaged $1.2 million across 5 years, with a median of $857000.0 in 2025.
- Annual changes were most pronounced in 2022 — Prepaid Assets tumbled 80.16% — and 2024, when it jumped 383.81%.
- Alaunos Therapeutics' Prepaid Assets stood at $799000.0 in 2022, then soared by 175.09% to $2.2 million in 2023, then slipped by 24.52% to $1.7 million in 2024, then tumbled by 63.83% to $600000.0 in 2025, then rose by 2.67% to $616000.0 in 2026.
- The last three Prepaid Assets figures came in at $616000.0 (Q1 2026), $600000.0 (Q4 2025), and $747000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 616,000.00 |
| Dec 31, 2025 | 600,000.00 |
| Sep 30, 2025 | 747,000.00 |
| Jun 30, 2025 | 857,000.00 |
| Mar 31, 2025 | 746,000.00 |
| Dec 31, 2024 | 1.66 Mn |
| Sep 30, 2024 | 1.87 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 1.89 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 925,000.00 |
| Jun 30, 2023 | 457,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | 799,000.00 |
| Sep 30, 2022 | 849,000.00 |
| Jun 30, 2022 | 1.35 Mn |
| Mar 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 1.67 Mn |
| Sep 30, 2021 | 3.32 Mn |
| Jun 30, 2021 | 5.04 Mn |